• Je něco špatně v tomto záznamu ?

Hydrogen sulfide alleviates lipopolysaccharide-induced myocardial injury through TLR4-NLRP3 pathway

Y. Xia, W. Zhang, K. He, L. Bai, Y. Miao, B. Liu, X. Zhang, S. Jin, Y. Wu

. 2023 ; 72 (1) : 15-25. [pub] 20221222

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23002228

To investigate the effect of hydrogen sulfide (H2S) on myocardial injury in sepsis-induced myocardial dysfunction (SIMD), male C57BL/6 mice were intraperitoneally injected with lipopolysaccharide (LPS) (10 mg/kg, i.p.) to induce cardiac dysfunction without or with the H2S donor sodium hydrosulfide (NaHS) (50 μmol/kg, i.p.) administration 3 h after LPS injection. Six hours after the LPS injection, echocardiography, cardiac hematoxylin and eosin (HE) staining, myocardial damage and inflammatory biomarkers and Western blot results were analyzed. In mice, the administration of LPS decreased left ventricular ejection fraction (LVEF) by 30 % along with lowered H2S levels (35 % reduction). It was observed that cardiac troponin I (cTnI), tumor necrosis factor-alpha (TNF-alpha), and interleukin-1beta (IL-1beta) levels were all increased (by 0.22-fold, 2000-fold and 0.66-fold respectively). HE staining revealed structural damage and inflammatory cell infiltration in the myocardial tissue after LPS administration. Moreover, after 6 h of LPS treatment, toll-like receptor 4 (TLR4) and nod-like receptor protein 3 (NLRP3) expressions were up-regulated 2.7-fold and 1.6-fold respectively. When compared to the septic mice, NaHS enhanced ventricular function (by 0.19-fold), decreased cTnI, TNF-alpha, and IL-1beta levels (by 11 %, 33 %, and 16 % respectively) and downregulated TLR4 and NLRP3 expressions (by 64 % and 31 % respectively). Furthermore, NaHS did not further improve cardiac function and inflammation in TLR4-/- mice or mice in which NLRP3 activation was inhibited by MCC950, after LPS injection. In conclusion, these findings imply that decreased endogenous H2S promotes the progression of SIMD, whereas exogenous H2S alleviates SIMD by inhibiting inflammation via the TLR4-NLRP3 pathway suppression.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23002228
003      
CZ-PrNML
005      
20230517133808.0
007      
ta
008      
230406s2023 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934928 $2 doi
035    __
$a (PubMed)36545872
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Xia, Yuxuan $u Department of Physiology, Hebei Medical University, Hebei, China
245    10
$a Hydrogen sulfide alleviates lipopolysaccharide-induced myocardial injury through TLR4-NLRP3 pathway / $c Y. Xia, W. Zhang, K. He, L. Bai, Y. Miao, B. Liu, X. Zhang, S. Jin, Y. Wu
520    9_
$a To investigate the effect of hydrogen sulfide (H2S) on myocardial injury in sepsis-induced myocardial dysfunction (SIMD), male C57BL/6 mice were intraperitoneally injected with lipopolysaccharide (LPS) (10 mg/kg, i.p.) to induce cardiac dysfunction without or with the H2S donor sodium hydrosulfide (NaHS) (50 μmol/kg, i.p.) administration 3 h after LPS injection. Six hours after the LPS injection, echocardiography, cardiac hematoxylin and eosin (HE) staining, myocardial damage and inflammatory biomarkers and Western blot results were analyzed. In mice, the administration of LPS decreased left ventricular ejection fraction (LVEF) by 30 % along with lowered H2S levels (35 % reduction). It was observed that cardiac troponin I (cTnI), tumor necrosis factor-alpha (TNF-alpha), and interleukin-1beta (IL-1beta) levels were all increased (by 0.22-fold, 2000-fold and 0.66-fold respectively). HE staining revealed structural damage and inflammatory cell infiltration in the myocardial tissue after LPS administration. Moreover, after 6 h of LPS treatment, toll-like receptor 4 (TLR4) and nod-like receptor protein 3 (NLRP3) expressions were up-regulated 2.7-fold and 1.6-fold respectively. When compared to the septic mice, NaHS enhanced ventricular function (by 0.19-fold), decreased cTnI, TNF-alpha, and IL-1beta levels (by 11 %, 33 %, and 16 % respectively) and downregulated TLR4 and NLRP3 expressions (by 64 % and 31 % respectively). Furthermore, NaHS did not further improve cardiac function and inflammation in TLR4-/- mice or mice in which NLRP3 activation was inhibited by MCC950, after LPS injection. In conclusion, these findings imply that decreased endogenous H2S promotes the progression of SIMD, whereas exogenous H2S alleviates SIMD by inhibiting inflammation via the TLR4-NLRP3 pathway suppression.
650    _2
$a myši $7 D051379
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a zvířata $7 D000818
650    12
$a sulfan $x farmakologie $x terapeutické užití $7 D006862
650    _2
$a lipopolysacharidy $x toxicita $7 D008070
650    _2
$a protein NLRP3 $7 D000071199
650    _2
$a TNF-alfa $7 D014409
650    _2
$a toll-like receptor 4 $x metabolismus $7 D051197
650    _2
$a tepový objem $7 D013318
650    _2
$a funkce levé komory srdeční $7 D016277
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a zánět $x patologie $7 D007249
650    12
$a sepse $x chemicky indukované $x komplikace $x farmakoterapie $7 D018805
650    12
$a kardiomyopatie $7 D009202
650    12
$a poranění srdce $7 D006335
655    _2
$a časopisecké články $7 D016428
700    1_
$a Zhang, Wenya $u Department of Physiology, Hebei Medical University, Hebei, China
700    1_
$a He, Kaichuan $u Department of Physiology, Hebei Medical University, Hebei, China
700    1_
$a Bai, Lu $u Department of Physiology, Hebei Medical University, Hebei, China
700    1_
$a Miao, Yuxin $u Department of Physiology, Hebei Medical University, Hebei, China
700    1_
$a Liu, Biyu $u Department of Physiology, Hebei Medical University, Hebei, China
700    1_
$a Zhang, Xiangjian $u Hebei Collaborative Innovation Center for Cardio-Cerebrovascular Disease, Hebei, China
700    1_
$a Jin, Sheng $u Department of Physiology, Hebei Medical University, Hebei, China
700    1_
$a Wu, Yuming $u Department of Physiology, Hebei Medical University, Hebei, China $u Hebei Collaborative Innovation Center for Cardio-Cerebrovascular Disease, Hebei, China
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 72, č. 1 (2023), s. 15-25
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36545872 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20230406 $b ABA008
991    __
$a 20230517133803 $b ABA008
999    __
$a ok $b bmc $g 1933556 $s 1188434
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 72 $c 1 $d 15-25 $e 20221222 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK198 $a Pubmed-20230406

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...